Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
Marionette lines are a common sign of aging, making the face appear saggy or downturned. According to board-certified plastic ...
As Stacey Leasca reports for “Food & Wine,” research from Cornell University found that households with at least one GLP-1 ...